{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:36:51Z","timestamp":1793813811209,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jep.2025.120788","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:17:33Z","timestamp":1761592653000},"page":"120788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Integrating network pharmacology and metabolomics to explore the mechanism of Xihuang Pill in exerting anti-tumor immune effects against pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"356","author":[{"given":"Zhiqiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2025.120788_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1452212","article-title":"PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9\/10-CXCR3-IFN\u03b3 positive feedback loop","volume":"15","author":"Abdala-Saleh","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jep.2025.120788_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112588","article-title":"The cross-talk between tumor-associated macrophages and tumor endothelium: recent advances in macrophage-based cancer immunotherapy","volume":"146","author":"Baradaran","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2025.120788_bib3","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jep.2025.120788_bib4","first-page":"1347","article-title":"Xihuang pill induces pyroptosis and inhibits progression of breast cancer cells via activating the cAMP\/PKA signalling pathway","volume":"13","author":"Chen","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jep.2025.120788_bib5","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1038\/s41467-024-48397-9","article-title":"FLI1 promotes IFN-\u03b3-induced kynurenine production to impair anti-tumor immunity","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jep.2025.120788_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13020-022-00687-4","article-title":"Integrated dose-response metabolomics with therapeutic effects and adverse reactions may demystify the dosage of traditional Chinese medicine","volume":"17","author":"Chen","year":"2022","journal-title":"Chin Med. Uk"},{"key":"10.1016\/j.jep.2025.120788_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/cns.13800","article-title":"Curzerene suppresses progression of human glioblastoma through inhibition of glutathione S-transferase A4","volume":"28","author":"Cheng","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jep.2025.120788_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/10409238.2021.1934811","article-title":"Cancer cells dysregulate PI3K\/AKT\/mTOR pathway activation to ensure their survival and proliferation: mimicking them is a smart strategy of gammaherpesviruses","volume":"56","author":"Cirone","year":"2021","journal-title":"Crit. Rev. Biochem. Mol."},{"key":"10.1016\/j.jep.2025.120788_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jare.2023.02.013","article-title":"CEACAM7 expression contributes to early events of pancreatic cancer","volume":"55","author":"Dhasmana","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jep.2025.120788_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcancer.2020.01.015","article-title":"Anti-inflammatory and anti-cancer activities of frankincense: targets, treatments and toxicities","volume":"80","author":"Efferth","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jep.2025.120788_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","article-title":"Current and future immunotherapeutic approaches in pancreatic cancer treatment","volume":"17","author":"Farhangnia","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jep.2025.120788_bib12","article-title":"Application of metabolomics for revealing the interventional effects of functional foods on metabolic diseases","volume":"A 367","author":"Fu","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.jep.2025.120788_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cac2.12416","article-title":"Tumor microenvironment signaling and therapeutics in cancer progression","volume":"43","author":"Goenka","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jep.2025.120788_bib14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","article-title":"Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity","volume":"55","author":"Hezaveh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jep.2025.120788_bib15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1470-2045(22)00284-4","volume":"23","author":"Howell","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jep.2025.120788_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101079","article-title":"TRIM29 facilitates gemcitabine resistance via MEK\/ERK pathway and is modulated by circRPS29\/miR-770-5p axis in PDAC","volume":"74","author":"Huang","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.jep.2025.120788_bib17","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-22-3042","article-title":"Metformin reprograms tryptophan metabolism to stimulate CD8+ T-cell function in colorectal cancer","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.jep.2025.120788_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2025.120788_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.216","article-title":"Targeted therapy for pancreatic ductal adenocarcinoma: mechanisms and clinical study","volume":"4","author":"Kung","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.jep.2025.120788_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jconrel.2025.02.021","article-title":"Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer","volume":"380","author":"Li","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jep.2025.120788_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.canlet.2021.09.012","article-title":"IDO1\/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer","volume":"522","author":"Liang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jep.2025.120788_bib22","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/s41379-022-01143-2","article-title":"Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma","volume":"35","author":"Mafficini","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jep.2025.120788_bib23","article-title":"Metabolic signaling in cancer","volume":"15","author":"Pinheiro","year":"2025","journal-title":"Csh Perspect Med."},{"key":"10.1016\/j.jep.2025.120788_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116198","article-title":"Qingyihuaji formula promotes apoptosis and autophagy through inhibition of MAPK\/ERK and PI3K\/Akt\/mTOR signaling pathway on pancreatic cancer in vivo and in vitro","volume":"307","author":"Qian","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2025.120788_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003521","article-title":"Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma","volume":"9","author":"Reschke","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jep.2025.120788_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103734","article-title":"Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo","volume":"74","author":"Siska","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jep.2025.120788_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12964-024-01523-y","article-title":"Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages","volume":"22","author":"Tankov","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jep.2025.120788_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118278","article-title":"The mechanism of Xihuang pills' intervention in the tumour immune microenvironment for the treatment of liver cancer based on the STAT3-PDL1 pathway","volume":"331","author":"Wang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2025.120788_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007253","article-title":"Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response","volume":"11","author":"Wang","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jep.2025.120788_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12967-025-06276-x","article-title":"IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment","volume":"23","author":"Wu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jep.2025.120788_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154764","article-title":"Xihuang Pill-destabilized CD133\/EGFR\/Akt\/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2","volume":"114","author":"Xu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2025.120788_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2055703","article-title":"Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism","volume":"11","author":"Yang","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jep.2025.120788_bib33","article-title":"Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2025.120788_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010162","article-title":"SIGLEC11 promotes M2 macrophage polarization through AKT-mTOR signaling and facilitates the progression of gastric cancer","volume":"13","author":"Yin","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jep.2025.120788_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jep.2025.120788_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114742","article-title":"A new discovery: total bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K\/Akt\/mTOR pathway","volume":"283","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2025.120788_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154491","article-title":"Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer","volume":"108","author":"Zhuang","year":"2023","journal-title":"Phytomedicine"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125014801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125014801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:45:17Z","timestamp":1776177917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874125014801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"alternative-id":["S0378874125014801"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2025.120788","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating network pharmacology and metabolomics to explore the mechanism of Xihuang Pill in exerting anti-tumor immune effects against pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2025.120788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120788"}}